Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma
Article first published online: 1 MAR 2013
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd
Volume 68, Issue 5, pages 629–636, May 2013
How to Cite
To cite this article: Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. Allergy 2013; 68:629−636, , , , , , , , , , , , , , , , , , .
Edited by: Hans-Uwe Simon
- Issue published online: 17 APR 2013
- Article first published online: 1 MAR 2013
- Manuscript Accepted: 11 DEC 2012
Table S1. COPD classification.
Table S2. Full list of metabolite names and metabolite classes.
Table S3. Metabolite population statistics.
Table S4. Selected candidate asthma SNPs for analysis.
Table S5. Results of logistic regression of metabolites on current, medicated and ever asthma status in KORA F4.
Table S6. Results of logistic regression of metabolites on asthma, COPD and atopic dermatitis in KORA F4.
Table S7. Further information on significant SNPs.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.